Filing Flows › Accuray (ARAY) › Recalls, complaints & regulation
Accuray (ARAY): recalls
Accuray (ARAY) beyond its filings: 2 recalls in the last 12 months (4 in five years, 0 Class I).
Latest recalls
- 2026-07-08 · FDA device · Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer; Linear Accelerator
- 2026-07-08 · FDA device · Cyberknife Treatment Deliver System equipped with the Xchange Robotic Collimator Changer; Linear Accelerator
- 2025-02-05 · FDA device · CyberKnife Treatment Delivery System, REF 0660000 The CyberKnife System may be labeled as CyberKnife M6TM or VSI TM Robotic Surgery System. The CyberKnife Tr
- 2023-09-06 · FDA device · Upper roller bracket (part number 1088370) for the Gen2 gantry enclosure for the Radixact Treatment Delivery System.
Accuray's latest quarter
Accuray, Q1 FY27: revenue $86.5M (-8% year over year), operating margin -42.2%, net earnings $10.1M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.
Questions
Has Accuray had any recalls?
4 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.